Ann Arbor Stage IIIB Hodgkin Lymphoma
3 clinical trials · Condition
◉ Watch Ann Arbor Stage IIIB Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| Nivolumab and Brentuximab Vedotin in Treating Older Patients With Untreated Hodgkin Lymphoma (NCT02758717) | Academic and Community Cancer Research United | 2016-05-13 |
| Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma (NCT02166463) | National Cancer Institute (NCI) | 2015-03-19 |
| Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma (NCT01771107) | National Cancer Institute (NCI) | 2013-03-08 |
Track Ann Arbor Stage IIIB Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.